$RCKT

$2.45 +$0.17 (7.46%) Close

$RCKT Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Company Executives

$RCKT Management Team

Dr. Gaurav Shah

Chief Executive Officer

Director

Age 50

Compensation $6.841M USD

Sex Male

Mr. Martin Wilson

Interim Principal Financial Officer

Senior Vice President

General Counsel

Age 48

Compensation $2.114M USD

Sex Male

Mr. Christopher Stevens

Chief Operating Officer

Age 45

Compensation -

Sex Male

Ms. Sarbani Chaudhuri

Chief Commercial and Medical Affairs Officer

Age 50

Compensation -

Sex Female

Dr. Kinnari Patel

President

Head of Research and Development

Age 46

Compensation $6.696M USD

Sex Female

Mr. Raj Prabhakar

Senior Vice President

Chief Business Officer

Age 51

Compensation $2.819M USD

Sex Male

Mr. John Militello

Principal Accounting Officer

Vice President - Finance

Treasurer

Age 51

Compensation $1.176M USD

Sex Male

Dr. Roderick Wong

Chairman of the Board

Age 48

Compensation $410.0K USD

Sex Male

Dr. Jonathan Schwartz

Chief Medical and Gene Therapy Officer

Age 61

Compensation $2.364M USD

Sex Male

Name / Title	Age	Compensation	Sex
Dr. Gaurav Shah Chief Executive Officer Director	50	$6.841M USD	Male
Mr. Martin Wilson Interim Principal Financial Officer Senior Vice President General Counsel	48	$2.114M USD	Male
Mr. Christopher Stevens Chief Operating Officer	45	-	Male
Ms. Sarbani Chaudhuri Chief Commercial and Medical Affairs Officer	50	-	Female
Dr. Kinnari Patel President Head of Research and Development	46	$6.696M USD	Female
Mr. Raj Prabhakar Senior Vice President Chief Business Officer	51	$2.819M USD	Male
Mr. John Militello Principal Accounting Officer Vice President - Finance Treasurer	51	$1.176M USD	Male
Dr. Roderick Wong Chairman of the Board	48	$410.0K USD	Male
Dr. Jonathan Schwartz Chief Medical and Gene Therapy Officer	61	$2.364M USD	Male

Board of Directors

From the proxy statement filed Apr 6, 2026

Directors

serving now

Independent

6 of 9

stated in the proxy

Average tenure

6.4 years

from year joined

CEO also chairs the board

Roderick Wong and Peter Fong

Director	Age	On board	Independent	Committees	Other public boards	2025 pay
Roderick Wong Board chair	49	2018 8 years	Not independent	None stated	Avidity Biosciences, Inc., Landos Biopharma, Inc.	$134,898
Carsten Boess	59	2016 10 years	Independent	Audit Committee · Chair	Avidity Biosciences, Inc., Achilles Therapeutics plc	$158,025
Mikael Dolsten	68	2024 2 years	Not independent	None stated	Agilent Technologies, Inc.	Not stated
Peter Fong Board chair	52	2025 1 year	Independent	None stated	None stated	$191,385
Fady Malik	62	2022 4 years	Independent	None stated	None stated	Not stated
Gaurav Shah CEO	51	2018 8 years	Not independent	None stated	Talaris Therapeutics, Inc.	Paid as CEO
David P. Southwell	65	2014 12 years	Independent	None stated	PTC Therapeutics Inc.	$138,650
Elisabeth Björk Leaving at the meeting	Not stated	Not stated	Independent	None stated	None stated	Not stated
Piratip Pratumsuwan Leaving at the meeting	Not stated	Not stated	Independent	None stated	None stated	$627,714

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

1 disclosed in the proxy filed Apr 6, 2026

Dr. Dolsten

a member of the Board

$125,000 paid in equal monthly installments and $125,000 of RSUs

2025

Consulting agreement with Dr. Dolsten for research and development services, effective March 3, 2025, terminated December 31, 2025; compensation of cash paid in monthly installments and RSUs that cliff vested December 31, 2025.

Open in proxy

Comments

Company Executives

$RCKT Management Team

Dr. Gaurav Shah

Mr. Martin Wilson

Mr. Christopher Stevens

Ms. Sarbani Chaudhuri

Dr. Kinnari Patel

Mr. Raj Prabhakar

Mr. John Militello

Dr. Roderick Wong

Dr. Jonathan Schwartz

Board of Directors

Related-party transactions